Cochrane Reviews on COVID-19 by the READ-It team

Cochrane Reviews: COVID-19

24 Mar 2021

Update (24 Mar 2021): Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

This is a review update of the original version (published 26 August 2020). The authors now include 64 study reports in 78 study cohorts, evaluating 16 antigen and 5 molecular assays.

Cochrane Systematic Review: UPDATE

16 Mar 2021

Update (16 Mar 2021) Thoracic imaging tests for the diagnosis of COVID‐19

Original version published on 30 September 2020.

This is the second update of this review. The review authors included studies in people with suspected COVID‐19 only, and excluded studies in people with confirmed COVID‐19. The evidence is up to date to 30 September 2020.

Cochrane Systematic Review: UPDATE

23 Feb 2021

Update (23 Feb 2021) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19

This review update will assess the diagnostic accuracy of signs and symptoms to determine if a person presenting in primary care or to hospital outpatient settings, such as the emergency department or dedicated COVID‐19 clinics, has COVID‐19.

Cochrane Systematic Review: UPDATE

12 Feb 2021

Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19

Hydroxychloroquine does not reduce deaths from COVID-19, and probably does not reduce the number of people needing mechanical ventilation, state the authors of a new Cochrane Review.

Cochrane Systematic Review: NEW

READ-IT

Search

Cochrane Reviews: COVID-19

Update (24 Mar 2021): Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

Update (16 Mar 2021) Thoracic imaging tests for the diagnosis of COVID‐19

Update (23 Feb 2021) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19

Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19

Contact us

Follow us